槲寄生의 항염증 효능 및 암세포 이주저해에 미치는 영향
The Effects of Gokgisaeng on Anti-inflammation and Rat C6 Glioma Cell Migration
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : Gokgisaeng (Korean mistletoe) is used for the treatment of inflammatory and cancer diseases in traditional Korean medicine and its major component lectins have been reported to induce nitric oxide (NO) in RAW 264.7 macrophages, and also induce apoptosis of various types of cancer cells, although its modulatory effects on cancer cell migration and macrophage activation is poorly understood. The aim of this study is to clarify molecular mechanisms of action responsible for the anti-inflammatory and antitumor migration potentials of Korean mistletoe extract (KME). Methods : We investigated the anti-inflammatory activity of KME on NO production and inducible nitric oxide synthase (iNOS) expression by lipopolysaccharide (LPS) in both RAW 264.7 macrophages and rat C6 glioma cells, and also evaluated inhibitory efficacy on glioma cell growth and migration. For assessment, XTT assay, nitrite assay, RT-PCR, scratch-wound and Boyden chamber assay, and western blot analysis were performed. Results : Previously reported, unlike the efficacy of Gokgisaeng lectin, KME inhibited NO production and iNOS expression, and suppressed pro-inflammatory mediators including IL-1β, IL-6, COX-2, iNOS in LPS-stimulated RAW 264.7 cells. Furthermore, KME suppressed tumor cell growth and migration, and it also inhibited LPS-induced NO release and iNOS activation by down-regulating expression of protein kinase C (PKC) and phosphorylation of ERK in C6 glioma cells. Conclusions : Our research findings provide evidence that KME can play a significant role in blocking pro-inflammatory reaction and malignant progression of tumors through the suppression of NO/iNOS by down-regulating of inflammatory signaling pathways, PKC/ERK.
Abstract
Objectives : Gokgisaeng (Korean mistletoe) is used for the treatment of inflammatory and cancer diseases in traditional Korean medicine and its major component lectins have been reported to induce nitric oxide (NO) in RAW 264.7 macrophages, and also induce apoptosis of various types of cancer cells, although its modulatory effects on cancer cell migration and macrophage activation is poorly understood. The aim of this study is to clarify molecular mechanisms of action responsible for the anti-inflammatory and antitumor migration potentials of Korean mistletoe extract (KME). Methods : We investigated the anti-inflammatory activity of KME on NO production and inducible nitric oxide synthase (iNOS) expression by lipopolysaccharide (LPS) in both RAW 264.7 macrophages and rat C6 glioma cells, and also evaluated inhibitory efficacy on glioma cell growth and migration. For assessment, XTT assay, nitrite assay, RT-PCR, scratch-wound and Boyden chamber assay, and western blot analysis were performed. Results : Previously reported, unlike the efficacy of Gokgisaeng lectin, KME inhibited NO production and iNOS expression, and suppressed pro-inflammatory mediators including IL-1β, IL-6, COX-2, iNOS in LPS-stimulated RAW 264.7 cells. Furthermore, KME suppressed tumor cell growth and migration, and it also inhibited LPS-induced NO release and iNOS activation by down-regulating expression of protein kinase C (PKC) and phosphorylation of ERK in C6 glioma cells. Conclusions : Our research findings provide evidence that KME can play a significant role in blocking pro-inflammatory reaction and malignant progression of tumors through the suppression of NO/iNOS by down-regulating of inflammatory signaling pathways, PKC/ERK.
참고문헌 (48)
- Aoki H, "Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model", Int J Hyperthermia, 20(6), pp.595~605 (2004)
- An YL, "Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells", Int J Nanomedicine, 6, pp.3187~3194 (2011)
- Amberger VR, "Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity", Cancer Res, 58(1), pp.149~158 (1998)
- Bello L, "Angiogenesis and invasion in gliomas", Cancer Treat Res, 117, pp.263~284 (2004)
- Yoo CH, "Effect of tamoxifen in C6 glioma cells", J Korean Neurosurg Soc, 26, pp.5~10 (1997)
- Agudelo-Garcia PA, "Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling", Neoplasia, 13(9), pp.831~840 (2011)
- Lamszus K, "Invasion as limitation to anti-angiogenic glioma therapy", Acta Neurochir Suppl, 88, pp.169~177 (2003)
- Deininger MH, "Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo", Acta Neuropathol, 98(3), pp.240~244 (1999)
- Kato S, "Immunohistochemical expression of inducible nitric oxide synthase(iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase(SOD) proteins(SOD1 and SOD2), Ki-67 antigen(MIB-1) and p53 protein", Acta Neuropathol, 105(4), pp.333~340 (2003)
- Lowenstein CJ, "Nitric oxide: a physiologic messenger", Ann Intern Med, 120, pp.227~237 (1994)
- Bonfoco E, "Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide", superoxide in cortical cell cultures, 1995, pp.92, 7162~7166
- Mukhopadhyay P, "Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin -induced cell death in vivo and in vitro", Am J Physiol Heart Circ Physiol, 296, pp.466~483 (2009)
- Enukidze MG, "Cell death in Jurkat cells induced by oxygen", nitrogen stress, 2009, pp.167, 109~113
- Singh S, "Nitric oxide: role in tumour biology and iNOS", NO-based anticancer therapies, 2011, pp.67, 1211~1224
- Pratheeshkumar P, "Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9", Eur J Pharmacol, 668, pp.450~458 (2011)
- Kostourou V, "The role of tumour-derived iNOS in tumour progression and angiogenesis", Br J Cancer, 104, pp.83~90 (2011)
- Lin WL, "Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells", Chem Biol Interact, 188, pp.607~615 (2010)
- Liu SG, "Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway", Mol Cancer Res, 9, pp.390~402 (2011)
- Wang J, "PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6", Cancer Lett, 311, pp.38~47 (2011)
- Hu JG, "Activation of PKC-alpha is required for migration of C6 glioma cells", Acta Neurobiol Exp, 70, pp.239~245 (2010)
- Lee KG, "Bee venom suppresses LPS -mediated NO", iNOS induction through inhibition of PKC-alpha expression, 2009, pp.123, 15~21
- Lin TH, "Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide", BMC Cancer, 8, pp.58~ (2008)
- Wen J, "Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells", J Neuroinflammation, 8, pp.38~ (2011)
- Lee YN, "New Flora of Korea", pp.261~ (2006), Kyo-Hak Publishing Co., Ltd
- Heo J, "Dong-eui-bo-gam", pp.2010~ (2007), Bupin Publishing Co., Ltd
- The Herbal medicine compilation committee of Oriental medicine college, "Herbal medicine", pp.331~333 (2006), Younglim Publishing
- Dae SM, "Hang-am-joong-cho-yak", pp.222~224 (1983), Kye- up-seogook-youhan-gongsa
- State Administration of Traditional Chinesemedicine, "Joong-hwa-bon-cho", pp.605~610 (2005), Sang-hae science technique Publishing
- 최옥병, "겨우살이 암치료제의 임상의학적 중요성과 한의학적 겨우살이 약침제제 개발 및 적용 가능성에 관한 고찰", Journal of Pharmacopuncture, 12(1), pp.77~89 (2009), 대한약침학회
- 김미정, "실험적 간암모델에서 한국산 겨우살이 추출물 및 렉틴 투여가 전암성 병변의 생성 및 Apoptosis에 미치는 영향", 한국식품영양과학회지, 31(5), pp.782~787 (2002), 한국식품영양과학회
- 김승욱, "상기생과 봉독이 간암 세포주 Hep G2에 대해 미치는 항암 기전 비교", 대한한방내과학회지, 30(4), pp.845~857 (2009), 대한한방내과학회
- 류광열, "桑寄生이 HepG2 cell의 세포분열 및 관련유전자 발현에 미치는 영향", 대한한방내과학회지, 26(1), pp.1~19 (2005), 대한한방내과학회
- 김지권, "茵蔯, 鬱金, 桑寄生, 瓦松이 HepG2 cell의 혈관생성인자 발현에 미치는 영향", 대한한방내과학회지, 28(1), pp.149~165 (2007), 대한한방내과학회
- 황석연, "Lectin으로 강화한 한국산 겨우살이 추출물의 in vitro 및 in vivo에서의 피부암에 대한 항암효과", 생약학회지, 34(3), pp.218~222 (2003), 한국생약학회
- 윤택준, "한국산 겨우살이 추출물의 in vivo 독성 및 항종양 효과", 생약학회지, 40(3), pp.205~212 (2009), 한국생약학회
- Korea Food & Drug Administration, "Korean Herbal medicine Standards exclusive of Pharmacopoeia", pp.46~ (2007), Shinilbooks Publishing
- Uisung-Dang editorial department, "Shin-nong -bon-cho-kyeong", pp.210~ (2012), Uisung-Dang Publishing
- Kim BK, "Protective effects of Korean mistletoe lectin on radical-induced oxidative stress", Biological and Pharmaceutical Bulletin, 33(7), pp.1152~1158 (2010)
- 이소진, "한국산 겨우살이의 산화적 DNA 손상 억제작용", 한국약용작물학회지, 11(2), pp.89~96 (2003), 한국약용작물학회
- Ham SS, "Antimutagenic effect of Korean mistletoe extracts", J of Korean Society Food Science and Nutrition, 27(2), pp.359~365 (1998)
- Lee CH, "Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo", International Immunopharmacology, 9, pp.1555~1561 (2009)
- Ju Hyun Lee, "Neuroprotective Effect of Korean Mistletoe Extract against DamageInduced by Hydrogen Peroxide in Cultured Rat Cortical Neurons", 한국약용작물학회지, 15(2), pp.105~111 (2007), 한국약용작물학회
- 김한수, "한국산 겨우살이 열수추출액이 본태성 고혈압쥐의지질성분 및 혈압 저하에 미치는 영향", 생약학회지, 37(3), pp.169~176 (2006), 한국생약학회
- 서지희, "한국산 겨우살이 전초의 Methanol 추출물로부터의 암세포증식 저해성분의 분리", 생약학회지, 35(2), pp.134~138 (2004), 한국생약학회
- Yoon TJ, "Fermented extracts of Korean mistletoe with lactobacillus(FKM-110) stimulate macrophage and inhibit tumor metastasis", Korean J of Food Science and Technology, 31(3), pp.838~847 (1999)
- Sang Ho Choi, "Mistletoe Lectin Induces Apoptosis and Telomerase Inhibition in Human A253 Cancer Cells through Dephosphorylation of Akt", Archives of Pharmacal Research, 27(1), pp.68~76 (2004), 대한약학회
- Park WB, "Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis", Cancer Biotherapy and Radiopharmaceuticals, 16, pp.439~447 (2001)
- Muntané J, "Nitric oxide and cancer", World J Hepatol, 2(9), pp.337~344 (2010)
